|
Basic Characteristics of Mutations
|
|
Mutation Site
|
A594V |
|
Mutation Site Sentence
|
Genotypic and phenotypic susceptibility assays demonstrated an A594V mutation in the UL97 phosphotransferase gene and GCV IC(50)>96 microM. |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
UL97 |
|
Standardized Encoding Gene
|
UL97
|
|
Genotype/Subtype
|
- |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Cytomegalovirus infections
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
GCV |
|
Location
|
- |
|
Literature Information
|
|
PMID
|
17605746
|
|
Title
|
Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient
|
|
Author
|
Garcia-Martinez J,Folgueira L,Delgado R,Hernando S,Prieto C,Aguado JM,Otero JR
|
|
Journal
|
Transplant infectious disease : an official journal of the Transplantation Society
|
|
Journal Info
|
2008 Apr;10(2):123-8
|
|
Abstract
|
We reported a ganciclovir (GCV)-resistant cytomegalovirus (CMV) infection in a heart transplant recipient. Genotypic and phenotypic susceptibility assays demonstrated an A594V mutation in the UL97 phosphotransferase gene and GCV IC(50)>96 microM. Low GCV concentration exposure, immunosuppressive treatment, donor-positive/recipient-negative CMV serostatus, viral reactivations within antiviral prophylaxis or treatment, contributed to GCV-resistant strain selection.
|
|
Sequence Data
|
-
|